Black Rock Inc. Regeneron Pharmaceuticals, Inc. Call Options Transaction History
Black Rock Inc.
- $4.35 Trillion
- Q2 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding REGN
# of Institutions
1,471Shares Held
85.8MCall Options Held
1.39MPut Options Held
1.45M-
Vanguard Group Inc Valley Forge, PA9.41MShares$4.83 Billion0.11% of portfolio
-
Jpmorgan Chase & CO New York, NY5.66MShares$2.91 Billion0.28% of portfolio
-
State Street Corp Boston, MA4.79MShares$2.46 Billion0.13% of portfolio
-
Capital International Investors Los Angeles, CA3.99MShares$2.05 Billion0.52% of portfolio
-
Geode Capital Management, LLC Boston, MA2.47MShares$1.27 Billion0.13% of portfolio
About REGENERON PHARMACEUTICALS, INC.
- Ticker REGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 107,190,000
- Market Cap $55.1B
- Description
- Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...